This is the perfect karma!
After Martin Shkreli and his company Turing Pharmaceuticals bought a drug called Daraprim last month and jacked up its price from $13.50 per pill to $750, the Internet exploded with outrage.
The drug, which is used mostly for patients with HIV/AIDS, become unaffordable for virtually everyone in its intended market overnight, and Shkreli became a national villain — one whom it turns out was pretty creepy in his personal life, too.
Now, though, Imprimis Pharmaceuticals has taken up the cause by making a significantly cheaper generic alternative to the drug — and it’s only going to cost patients $1 per pill!
The Imprimis Cares program is set to make drugs similar to Daraprim far more affordable to consumers. According to CEO Mark L. Baum:
“While we respect Turing’s right to charge patients and insurance companies whatever it believes is appropriate, there may be more cost-effective compounded options for medications, such as Daraprim, for patients, physicians, insurance companies and pharmacy benefit managers to consider.”
That’s such a relief!
And hopefully Mr. Shkreli learned a lesson with this news, too!
Though we’re not hold our breath…
[Image via Martin Shkreli/Twitter.]